EFTA Document EFTA01492769

FINANCIAL TRUST COMPANY INC ACCT. W23560001 For the Period 2/1/12 to 2/29/12 Note P indicates position adjusted for Pending Trade Activity. Unrealized Gain Loss is shown as "N A" in cases where we do not have appropriate cost information for all lax lots comprising the position. Please contact your J P Morgan team for additional information. Equity Detail Price Quantity Value Adjusted Tax Cost Unrealized Gaintoss Est. Annual Inc Original Cost Accrued Div. Yield US Large Cap Equity ARIAD PHARMACEUTICALS INC 14.35 18,535.000 237,277.25 251,475.52 (14,198.27) 04033A-10-0 ARIA BIOGEN [DEC INC 116.47 2,095.000 244,004.65 250,454.95 (6,450.30) 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 86.52 1,003.000 000 865,200.00 1,000,000.00 (134,80000) 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07,15,11 MS 21 09 2515A1-A7-6 P FIRST REPUBLIC BANK SAN FRAN 29.99 000 33616C-I0-0 FRC HSBC MARKET PLUS SPX 05/17/13 100.03 5,000,000.000 5,001,500.00 5,003,000.00 1,500.00 72% KO BARRIER- 0%CPN ,UNCAPPED INITIAL LEVEL-02/14/12 SPX:1350.50 4042K1-X0-1 P ONEOK PARTNERS LP 58.20 0.00 4.19% 682613N-10-3 OKS JP Morgan Account W23560001 Page 5 of 33 Consolidated Statement Page 8 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00015582 SDNY_GM_00284780 EFTA01492769